Category: Creating Tomorrow

Published: May 2026

For Welch LLP, supporting The Ottawa Hospital isn’t tied to a single moment. It’s something that has built over time, shaped by personal experiences, long-standing involvement, and a shared commitment to giving back across the firm.

For over 100 years, Welch LLP, founded in 1918, has been recognized as one of Ottawa’s oldest companies. What began as a local accounting practice has grown into a full-service accounting and advisory firm with 12 offices across Ontario and Quebec, 39 partners, and more than 390 employees.

Despite that growth, the firm continues to see itself as deeply rooted in Ottawa. That local focus has shaped not only Welch LLP’s business, but also its support for The Ottawa Hospital. This has included a long-standing involvement in initiatives such as The Ottawa Hospital Foundation’s President’s Breakfast, where partners have played a key role in helping strengthen participation by hosting tables, securing sponsorship, and encouraging engagement across their networks.

Over the years, that support has also taken shape through a multi-year initiative that brought together several Welch LLP offices, including Ottawa, Pembroke, Quinte, and Cornwall, to raise more than $100,000 for The Ottawa Hospital’s Dermatology Centre.

A new chapter of giving

Now, Welch LLP is marking a new chapter in their support with a $250,000 gift to the Campaign to Create Tomorrow — The Ottawa Hospital Foundation’s $500 million fundraising campaign to build a new, state-of-the-art Civic Campus. This marks the largest gift in the firm’s history through its newly established charitable foundation.

“It’s where our families receive care and where we see the needs of our community firsthand.”

— Jim McConnery

Created in 2022, the Welch Community Foundation was formed after the COVID-19 pandemic to bring more focus and coordination to the firm’s giving. Funded entirely by partners, it allows Welch LLP to pool contributions and collectively decide where they can have the greatest impact.

Guided by the firm’s vales of care, impact, and empowerment, supporting The Ottawa Hospital was a natural choice.

“We’ve had a long connection to The Ottawa Hospital, and it’s something that matters to many people across our firm,” says Jim McConnery, Managing Partner of Welch LLP’s Ottawa office. “It’s where our families receive care and where we see the needs of our community firsthand.”

When impact is personal

In recent years, that connection has become even more personal. Members of the firm have required care at The Ottawa Hospital, giving colleagues a firsthand view of the expertise, compassion, and innovation that define the care our hospital provides.

For many at Welch LLP, it also deepened their understanding of our hospital’s role not just in delivering care, but in advancing it. From leading-edge treatments to world-class research, the impact extends far beyond any individual patient.

“We know The Ottawa Hospital is critical to the community, but the more you learn about it, the more compelling it becomes,” says Jim. “The level of care, the innovation, and the research taking place here in Ottawa are truly impressive and they’re making a real difference for patients.”

Across generations

Welch LLP’s involvement with The Ottawa Hospital is also being shaped by its next generation of partners.

Several emerging leaders across the firm are now stepping into community roles of their own — including participation in Young Leaders, sponsored by RBC, a program led by The Ottawa Hospital Foundation to encourage young adults to get involved through organized events. Their involvement is helping broaden the firm’s connection to our hospital, bringing new energy to the firm’s commitment to supporting our community.

“Many, if not all of us will need to rely on the care The Ottawa Hospital provides at some point in our lives and that is why this initiative is so important.”

— Alessandro D’Angelo

For a firm that has spanned more than a century, there is a strong emphasis on carrying that commitment forward with emerging leaders. With generations of families building careers at Welch LLP, there is a shared understanding that supporting healthcare is not only about making a difference today, but also ensuring strong, accessible care for the next 100 years.

“Welch LLP has always taken a long view, and that responsibility now sits with the next generation. Our support of The Ottawa Hospital reflects a commitment we intend to carry forward, as strong healthcare systems are essential to strong communities, now and in the future,” says Alessandro D’Angelo, Partner at Welch LLP. “Many, if not all of us will need to rely on the care The Ottawa Hospital provides at some point in our lives and that is why this initiative is so important. Our family has had three children at the hospital’s General Campus, and we have experienced firsthand the type of excellent care provided, it’s now our responsibility to give back and ensure that everyone in Ottawa has access to state-of-the art care and facilities at the scale needed to keep pace with the city’s growth.”

As The Ottawa Hospital moves forward with the Campaign to Create Tomorrow, Welch LLP’s $250,000 gift reflects that long-term view — an investment in the future of care for the community.

Categories: Creating Tomorrow, Donors

Published: May 2026

As the largest global law firm, Dentons is known for advising local, national and international clients on complex legal matters including venture tech, corporate commercial, banking, real estate and infrastructure, telecommunications, litigation, employment, regulatory, IP and privacy. But in Ottawa, the firm’s impact extends well beyond the work it does for clients.

For years, Dentons has been a familiar and enthusiastic supporter of The Ottawa Hospital. From The Ottawa Hospital Foundation Gala to the President’s Breakfast for the Public Service, the firm has helped bring the community together in support of better care and groundbreaking research.

Now, Dentons is taking that commitment one step further with a combined contribution of $260,000 to the Campaign to Create Tomorrow, including personal contributions from a group of senior members of the Ottawa office and a corporate gift.

A relationship built through leadership

The firm’s connection to the hospital was shaped in large part by longtime partner Greg Kane — a respected and influential leader in Ottawa’s legal and philanthropic communities. Greg served on both The Ottawa Hospital Foundation Board and the Board of the Ottawa Hospital Research Institute, where he supported the hospital’s mission over many years.

“When Greg joined our firm, he was already deeply involved with The Ottawa Hospital,” says David Little, Partner at Dentons. “That created an opportunity for us to become more involved as a firm and to support the initiatives we all care about. Over time, that relationship continued to grow.”

Although Greg has since retired, the foundation he helped build continues to guide the firm’s approach to giving.

Rooted in Ottawa

While Dentons is a global firm, its Ottawa office is rooted in the local community, with many lawyers and staff building long careers in the city.

“Supporting projects like this allows us to make meaningful contributions to the growth of our city not just today, but for the future.”

— David Little
Chase Irwin, Tim Kluke, and David Little at President’s Dinner 2026.

“We really pride ourselves on being part of the communities where we live and work,” says David. “Supporting projects like this allows us to make meaningful contributions to the growth of our city not just today, but for the future.”

That commitment is reflected in the firm’s decision to support a project of this scale. For Dentons, the Campaign to Create Tomorrow represents more than a fundraising effort, it’s a chance to have a lasting impact.

A shared investment in the future

Today, that spirit of giving continues under the leadership of Managing Partner Chase Irwin, who sees the campaign as both a community-building opportunity and a moment for organizations, like Dentons, to step forward.

Dentons Ottawa at President's Dinner 2026.

“This is an opportunity for organizations in our community to make a profound impact.”

— Chase Irwin

“This is an opportunity for organizations in our community to make a profound impact,” says Chase. “Supporting this campaign allows us to contribute to something that will benefit Ottawa for generations to come.”

A new hospital campus will transform how care is delivered in our region — bringing together cutting-edge research, modern facilities and ongoing advances in care.

For the Dentons team, the impact is personal. Across generations, from younger professionals to long-time leaders, there is a shared understanding this hospital will touch everyone in the community at some point in their lives.

Recently, the firm also came together to honour the memory of former partner and dear friend Alex Kilgour, supporting cancer care and research through donations made in his name. It’s another reflection of the deep and personal connections that continue to shape Dentons’ commitment to The Ottawa Hospital.

As organizations across Ottawa step forward to support the campaign, Dentons is proud to be part of a collective effort helping shape the city’s story for the next 100 years.

Categories: Creating Tomorrow, Donors

In 2021, we lost Boston to his struggle with mental health. He was a loving son, a caring older brother, a loyal friend, and the life of the party, and he was taken from us far too soon. The Boston Classic is an ode to him and his love of golf, summer, and being with those he loved. It is an opportunity for us to remember and honour him as well as raise awareness about men’s mental health and funds for The Ottawa Hospital in Boston’s name.

The 5th annual tournament is taking place on Saturday, June 6th, 2026, at the Meadows Golf and Country Club. For tickets & more information on how you can support, visit TheBostonClassic.com.

Published: April 2026

Read time: 4 min

Published: April 2026

Read time: 4 min

On Christmas Day 2023, Jody Stang fell to the kitchen floor. When his brother stopped by for a visit, he found Jody sitting with his back pressed against the cupboards — unable to get back up on his own. This wasn’t like him.

Jody served 31 years in the Canadian Armed Forces, including six operational tours in Afghanistan, Bosnia, Cyprus, and Croatia. He was in peak shape: he walked regularly, cycled long distances, and kept up with weight training.

But in the months leading up to the fall, something felt different. His balance was off, his legs seemed weaker, and for the first time in decades, Jody missed the local Remembrance Day ceremony — a day that is deeply personal to him. Soon, he could no longer drive, and even walking short distances was a challenge.

What started as numbness in his baby toe was clearly becoming something much more serious.

Jody in hospital before spinal cord surgery.

Searching for answers

The day after his fall, Jody called an ambulance and was taken to the Cornwall Community Hospital. After some initial tests, physicians arranged for him to be transferred to The Ottawa Hospital. With one of the strongest neurology teams in the nation, The Ottawa Hospital is the only centre in the region equipped to provide the advanced neurological care he needed.

Doctors initially suspected MOG antibody-associated disease (MOGAD), a rare autoimmune disorder where the immune system attacks the protective layer of the nerves in the brain, spinal cord, and optic nerves, which would explain Jody’s muscle weakness and numbness.

He was started on high-dose steroids and later returned to Cornwall for continued care and rehabilitation. But instead of improving, Jody continued to decline. By then, he had lost nearly 85% of the sensation and motor function in his legs and was dependent on a wheelchair.

Jody recovering at our hospital following spinal cord surgery.

An unexpected diagnosis

Dr. Giulia Fadda, a neurologist and specialist in MOGAD at The Ottawa Hospital, saw Jody for a follow-up appointment in early February. Immediately concerned, she arranged for him to return as an inpatient to the neurology unit.

Five rounds of plasma exchange followed — a treatment option for more advanced stages of the disease. Still, there was no improvement.

His medical team ordered more imaging, including an MRI and PET scan, which revealed subtle changes near Jody’s L1/L2 vertebrae. The scans raised suspicions, and Dr. Safraz Mohammed, neurosurgeon at The Ottawa Hospital, recommended a biopsy.

The results revealed what no one had expected.

“Symptoms can mimic other neurological conditions, which makes early detection especially challenging.”

— Dr. Safraz Mohammed

Jody had the highest grade of brain tumour, called glioblastoma, but instead of being in his brain, it was in his spinal cord, which is incredibly rare. 

“Spinal cord glioblastoma is incredibly uncommon,” explains Dr. Mohammed. “Symptoms can mimic other neurological conditions, which makes early detection especially challenging.”

The reality of spinal cord glioblastoma

Glioblastoma is one of the most aggressive forms of cancer. But glioblastoma in the spinal cord is exceptionally rare and complex to treat — fewer than 200 cases have been documented in reported literature worldwide. This type of cancer is often devastating, typically leading to paralysis as it infiltrates the spinal cord.

The diagnosis explained the numbness and weakness in Jody’s legs, and he grappled with the news that life-long paralysis was now inevitable. But nothing could have prepared him for the news that came next.

For a cancer like glioblastoma, average life expectancy is usually measured in months. Jody was told he likely had less than one year to live.

“I was shocked,” says Jody. “But through all my years as a soldier, I’ve learned to take difficult circumstances one day at a time. You can take the man out of the army, but you can’t take the army out of the man.”

It was then that Dr. Mohammed presented an option that offered some hope.

Surgery remained a possibility. While it couldn’t reverse the damage already done, removing the tumour offered the best chance of extending Jody’s life.

“By the time we confirmed the diagnosis, Jody had already lost most of the strength in his legs,” says Dr. Mohammed. “But based on the location of the tumour, we had a surgical opportunity to remove the tumour completely, which we can’t often do with glioblastomas of the brain.”

Meet Neurosurgeon Dr. Safraz Mohammed

Find out more about how Dr. Mohammed is pushing the boundaries of neurosurgery and commitment to educating the next generation of doctors.
Read our Q&A with Dr. Mohammed

Canadian-first surgery lights the way

Under Dr. Mohammed’s care, Jody underwent a groundbreaking surgery with a fluorescence-guided microscope, funded by generous community donors.

Several hours before the operation, Jody drank a liquid containing 5-aminolevulinic acid (5-ALA), a compound that accumulates in cancerous cells but not healthy ones. Under a specific blue wavelength of light generated by the microscope, the malignant glioma in Jody’s spine glowed a fluorescent pink.

“While we use this technology in brain tumour surgery all the time, it had never been applied to the spine in Canada,” says Dr. Mohammed.

Prior to Jody’s procedure, The Ottawa Hospital was the first centre in Canada to adopt widespread routine use of 5-ALA in tumour surgery. Today, the hospital is considered a national leader in fluorescence-guided neurosurgery.

Now, with the cancer cells clearly visible, Jody’s surgical team was able to remove all the tumour tissue with extraordinary precision, while preserving as much surrounding healthy spinal cord as possible. The surgery was a success and offered Jody something he hadn’t expected after his diagnosis — more time with loved ones.

All about fluorescence-guided surgery and 5-ALA

Learn more about fluorescence-guided surgery and the “pink drink” shedding light for surgeons seeking out brain and spinal cord tumours.
Learn more

Ongoing treatment and recovery

Surgery was only the first step. In the weeks that followed, Jody underwent 30 rounds of radiation therapy alongside oral chemotherapy to target any remaining cancer cells and reduce the risk of recurrence. The chemotherapy continued for six months — the standard regimen for glioblastoma.

Regular follow-up appointments and scans also remain an essential part of his care. For Jody, who uses a motorized wheelchair, telehealth has made that ongoing care far more accessible. “Telehealth allows patients like Jody to be monitored and supported from their own home,” says Dr. Garth Nicholas, Jody’s primary oncologist. “We can adjust treatment, check on side effects, and answer questions without the added strain of regular travel.”

Advances in technology at The Ottawa Hospital are not only transforming surgery — they’re reshaping how care continues long after the operating room.

Hope for the future

Though his road to recovery hasn’t been without its challenges, Jody remains in good spirits. There was a time when he believed he would not see another Christmas. After being told he had approximately one year to live, Jody began preparing for the end — arranging a burial plot and purchasing a tombstone.

Jody back at home after recovering from a Canadian-first spinal cord surgery at The Ottawa Hospital.

Today, more than two years later, his latest scans show no evidence of cancer.

“I’m incredibly thankful,” says Jody. “For the care I received from my healthcare team and for the chance to have more time with friends and family.”

Jody’s outcome is a testament to what’s possible when innovation, expertise, and donor-supported technology come together.

Categories: Cancer, Innovation and Technology, Neuro, Patient Care

Published: March 2026

Read time: 3 min

Published: March 2026

Read time: 3 min

Kidney disease is often silent in its earliest stages, quietly damaging the body long before symptoms present themselves. By the time traditional tests detect it, the kidneys have already experienced irreversible damage. Roughly 1 in 10 people live with kidney disease, and many are unaware they are at risk.

Dr. Dylan Burger, a senior scientist at The Ottawa Hospital, is working to change that. Thanks to donor support through an ELEVATE seed grant, he and his team are developing ways to detect kidney stress as it happens and to protect these vital organs before lasting damage occurs.

Why the kidneys matter

The kidneys do far more than filter waste from the blood. Every minute, they carefully regulate blood pressure, balance fluids and electrolytes, produce hormones that support red blood cell production, and help maintain healthy bones and muscles.

When kidney function begins to decline, the effects are felt throughout the entire body — often before a diagnosis is even made. Rising blood pressure, anemia, fatigue, muscle weakness, calcium and vitamin D deficiencies, and fluid buildup can all signal that the kidneys are under strain. Over time, declining kidney function can also contribute to a higher risk of bone fractures and heart disease.

Kidney disease doesn’t occur all at once. It typically develops over time, beginning with subtle cellular stress before progressing to chronic kidney disease, if left untreated. In severe cases, it can lead to kidney failure, which requires regular dialysis or a kidney transplant to survive.

“Earlier insight gives us more options,” says Dr. Burger. “And more options can mean a very different future for patients.”

The kidneys play a vital role in regulating blood pressure, balancing fluids, and filtering waste from the body.

Tiny messengers with big potential

At the centre of Dr. Burger’s research are extracellular vesicles — tiny particles released by kidney cells and passed into the urine. These act as biological messengers, providing information about the health of kidney cells in real time.

“When kidney cells are stressed or injured, they release very specific vesicles,” explains Dr. Burger. “In studying those signals, we can gain insight into what’s happening in the kidney long before traditional tests show there is an issue.”

His team has discovered that when specific kidney cells called podocytes are damaged, they release vesicles with a distinct size and characteristics. These vesicles act as early warning signs, flagging kidney injury at a stage when damage may still be reversible.

While some vesicles indicate injury, others have the power to play a protective role. “Cells also release beneficial vesicles that promote regeneration and the health of the cells around them,” explains Dr. Burger. He notes his team is also looking at ways to harness these cells to repair and protect the kidney from further damage.

Meet Dr. Dylan Burger

The Ottawa Hospital is changing what we know about kidney disease and how we treat it. Meet Dr. Dylan Burger, just one of the experts whose practice-changing research is helping patients today and changing the kidney care of tomorrow.
Q&A with Dr. Burger

From the lab to the bedside

For people living with kidney disease, the consequences are often life-altering. Dialysis can require hours of treatment multiple times a week, if not every day. Transplant eligibility depends on timing, overall health, and availability of donor organs. That’s why Dr. Burger’s research is so critical.

Mauro Burri as a child.

Research like this has the potential to change what a kidney disease diagnosis means for patients like Mauro Burri. For Mauro, kidney disease didn’t just affect his health, it shaped his entire life. Diagnosed more than 51 years ago, Mauro has lived with kidney disease since he was just five years old. Kidney disease can have many causes, but at the time, doctors were unable to determine what led to Mauro’s.

“The hope is that research like this could change the future for patients, so that kidney disease doesn’t have to define someone’s life.”

— Mauro Burri

Over the decades, Mauro’s life has been marked by treatments; years on dialysis, including both peritoneal and hemodialysis; and the hope and uncertainty that comes with transplant surgery. “Even a successful transplant is not a cure,” explains Mauro.

He reflects on long hours hooked up to dialysis machines and the uncertainty of waiting for a compatible donor kidney. Today, Mauro is living with his third transplanted kidney — a reminder of the resilience required of patients and the ongoing challenges they face, both physically and mentally. His journey reflects the long and unpredictable path of many kidney disease patients.

This is where Dr. Burger’s research is transformative. His work could help patients like Mauro avoid years of dialysis, delay or even prevent the need for transplant, and maintain their quality of life.

Changing the course of kidney disease for the next generation

For someone who has lived with kidney disease for more than half a century, the implications are significant for Mauro. “The hope is that research like this could change the future for patients, so that kidney disease doesn’t have to define someone’s life,” he says.

“It feels good to give back and support research that could change the course of kidney disease for the next generation.”

— Mauro Burri

Mauro has also been actively involved in helping raise funds for kidney research, supporting work like Dr. Burger’s through The Kidney Foundation of Canada’s La Serata Italiana gala, which helps generate both funding and awareness for The Ottawa Hospital’s Kidney Research Centre. Established in 2000, the Kidney Research Centre is Canada’s first research facility devoted exclusively to investigating diseases that attack the kidney.

“It feels good to give back and support research that could change the course of kidney disease for the next generation,” says Mauro.

Mauro Burri is a patient impacted by kidney disease.

National recognition for groundbreaking work

Dr. Burger’s work is gaining national attention. He is the most recent recipient of the Dr. John B. Dossetor Research Award from The Kidney Foundation of Canada, one of the country’s most prestigious honours for his line of work. The award recognizes excellence, leadership, and innovation that advance the future of kidney care.

While he is incredibly grateful, Dr. Burger remains focused on what lies ahead. “The real impact,” he says, “is what this research could mean for individuals impacted by kidney disease.”

Advancing discovery in kidney care

Innovative kidney research projects, like Dr. Burger’s, have received critical early-stage funding through the Ottawa Hospital Research Institute’s ELEVATE seed grants, funded in part by donor support to The Ottawa Hospital Foundation. These grants help researchers test bold ideas that may one day improve the lives of patients, not only in Ottawa, but globally.

Donor support has also played a vital role in advancing kidney research by helping scientists push boundaries, train the next generation of researchers, and translate discoveries from the lab to the clinic faster than ever before.

For Dr. Burger, that support fuels his goal of changing what a kidney diagnosis could mean for patients. “If we can identify kidney stress earlier and protect the kidneys before damage becomes permanent,” he says, “we can give people a much better quality of life. It would be life-changing.”

Categories: Kidney, World-Leading Research

Published: February 2026

Few people have shaped the course of health research in Ottawa and beyond as profoundly as Dr. Ronald G. Worton. From discovering critical gene mutations to becoming the first CEO and Scientific Director of The Ottawa Hospital Research Institute (OHRI), Dr. Worton helped establish a culture of scientific excellence that continues to define our hospital today. When he arrived in Ottawa in 1996 to help build the hospital’s research program, he brought a collaborative vision that helped shape research at The Ottawa Hospital (TOH), and in the research community at large, for decades to come. And now, even in his retirement, Dr. Worton continues to give back and support the future of healthcare.

A trailblazer in genetic research

Dr. Worton’s path to medicine and research was anything but linear. Growing up in Winnipeg, Dr. Worton initially pursued physics. A chance carpool with biology students, who were energized by emerging discoveries about DNA, sparked his interest in biomedical research. That set him on a new path, first to a master’s degree in radiation physics at the University of Manitoba, and then to stem cell research for a PhD in Medical Biophysics at the University of Toronto.

Dr. Ronald G. Worton

Recruited to the newly established Genetics Department at Toronto’s Hospital for Sick Children, Dr. Worton emerged as a trailblazer in genetic research. As head of a research team, he helped discover the dystrophin gene, demonstrating that mutations in this gene cause Duchenne muscular dystrophy. At the time, gene discovery was still in its earliest stages, and this breakthrough helped lay the foundation for the Human Genome Project, a global effort to map all human genes and transform how scientists understand disease.

“What makes research thrive isn’t competition. It’s collaboration, shared ideas, and a willingness to support one another.”

— Dr. Ronald G. Worton

For Dr. Worton, what has been most meaningful is seeing how research into Duchenne muscular dystrophy has continued to advance over time, especially by scientists he recruited to OHRI. He notes the work of Dr. Michael Rudnicki, a senior scientist in regenerative medicine, and Director of the Sprott Centre for Stem Cell Research. Dr. Rudnicki’s team is conducting promising research that could one day lead to new treatment options with the potential to change the lives of children with muscular dystrophy.

When reflecting on this, Dr. Worton shares, “What makes research thrive isn’t competition. It’s collaboration, shared ideas, and a willingness to support one another.”

Dr. Worton, the first CEO and Scientific Director of The Ottawa Hospital Research Institute

Contributing in new ways

This spirit of collaboration shaped Dr. Worton’s approach to leadership and to giving back. When he retired in 2007, colleagues, friends, and supporters came together to establish the Dr. Ronald G. Worton Researcher in Training Award. While it originally recognized outstanding research by students and postdoctoral fellows across all disciplines, the award is now focused on those trainees who specialize in lab-based research.

When considering how best to give back in support of our hospital, Dr. Worton noted that this Researcher in Training Award was supported by a strong endowment fund that was fulfilling its purpose, so he shifted focus to supporting our Campaign to Create Tomorrow. He saw the campaign as an opportunity to contribute to the future of healthcare in a meaningful way.

Now, with a $50,000 commitment, Dr. Worton has stepped forward, not only as a major donor, but also as a Campaign Patron. He hopes his gift will encourage other community leaders to follow suit, just as he was inspired by Campaign Patron and former long-time President and CEO of The Ottawa Hospital, Dr. Jack Kitts.

“Becoming a Campaign Patron felt like the right way to contribute and to support this next chapter. I hope that by stepping forward, I can inspire other leaders to give as well,” says Dr. Worton.

Passing the torch to young researchers

To this day, Dr. Worton remains deeply engaged with the hospital and research community he helped build. His support reflects a belief in what the new hospital campus and its research will make possible for patients, researchers, and our community for generations to come.

“In one way or another, I hope this gift supports young researchers, providing them with the space, tools, and opportunities they need to fuel the next generation of discovery.”

— Dr. Ronald G. Worton

That belief in the power of research has guided his distinguished career and is reflected in the honours he has received, including induction into the Canadian Medical Hall of Fame and appointment as an officer of the Order of Canada.

“In one way or another, I hope this gift supports young researchers, providing them with the space, tools, and opportunities they need to fuel the next generation of discovery,” says Dr. Worton.

Through his leadership and philanthropy, Dr. Worton is passing the torch — investing in discovery, empowering the next generation of researchers, and ensuring a strong future for healthcare in our community and beyond.

Categories: Creating Tomorrow, Donors

More Events

The Craig Kulig Memorial Fund
Dec 31 - 2025 — (ONGOING) Canadian artist Darlene Kulig has created stunning t-shirts with proceeds donated to the Craig Kulig Memorial Fund supporting Cancer Research at The Ottawa Hospital
2026 Mertikas Calendars of Hope
Dec 31 - 2025 — (ONGOING) Support The Ottawa Hospital by purchasing a 2026 calendar featuring the incredible work of Ottawa artist Katerina Mertikas, a renowned UNICEF artist since 1993.
United to End ALS Comedy Night
Jan 24 - 2026 — Your efforts and attendance at these events not only help raise awareness but also directly contribute to supporting ALS research and patient care.
Sign up to receive updates on the transformational care taking place right here at our hospital, inspiring patient stories, and the latest research discoveries impacting healthcare for you, your loved ones, and our community.